Home Page

Types of Chemotherapy Agents

Names for Cancer Drugs

The Cell Cycle

Alklylating Agents

Kinase Inhibitors

Targets of  Small Molecule Kinase Inhibitors

Mechanism of kinase inhibitors

Kinase Protein Substrates and Drug Targets

Other Small Molecule Signal Induction Inhibitors

Vinca Alkaloids



Aromatase Inhibitors

Topoisomerase Inhibitors

mTor Inhibitors

Selective Inhibitors of Nuclear Export


HDAC inhibitors

PARP inhibitors

IDH Inhibitors

Antibody-Drug Conjugates

Plant Alkaloids

Targeted Therapies

Specific Drugs

Medicines Approved for Specific Cancers (A-D)

Medicines Approved for Specific Cancers (E-L)

Medicines Approved for Specific Cancers (M-Z)

A list

Personalized Therapy

Combination Chemotherapy


Companion Diagnostics

Adjuvant Chemotherapy

Neoadjuvant Chemotherapy

Evaluation of Chemotherapy Treatment

Allergies to chemotherapy agents

Modeling cancer growth with mathematics

Drug resistance

Chemoprotective Drugs

Chemotherapy agents on WHO List of Essential Medicines

Chemotherapy Drug Discovery and Development

Development Failures

Approval Process for New Drugs

Regulation and Market Power

Future of chemotherapy

Expanded Access Program for Oncology Drugs

Bringing Oncology Drugs to Market

The Chemotherapy Drug Industry

The War on Cancer

History of Chemotherapy

Why are prices high?

Clinical Trials for Oncology Drugs

Endpoints and Evidence of Efficacy

Response Evaluation Criteria in Solid Tumors

Chemotherapy in Bigger Picture of Cancer Treatment

Methods for Administering Chemotherapy

Where do patients get chemotherapy?

Oral Chemotherapy

Metronomic Chemotherapy

Scheduling Chemotherapy

Dose-dense Administration

Variable Dose Regimens

Explanation of First-line and Second-line Chemotherapy Regimens

Salvage Chemotherapy

Long-term cancer management and control

Chemotherapy Pharmacokinetics

Metabolism of Chemo Drugs

Drug-Drug Interactions

Chemotherapy in the Elderly

Pharmacogenomics and Oncology

About Tumors

Carcinogens and the origins of cancers


Cancer – imbalance in homeostasis

Angiogenesis Inhibitors

Regional Administration

Monoclonal Antibodies

Clinical Use of Monoclonal Antibodies

Antibody Targets

Biosimilars for Cancer Treatment

Off-label Use of Chemotherapy Drugs

Secondary Cancers Caused by Chemotherapy

Green Chemotherapy

Workplace Hazards Posed by Chemo Agents

Home Storage and Disposal

Brown-Bagging Chemotherapy


DIY Chemotherapy

Questions to Ask Your Doctor

Pregnancy and Chemotherapy

Adaptive Chemotherapy


New Drugs for Cancer

Questions about Chemotherapy in near future

Tumor-Agnostic Drugs

Synthetic Lethality

Fractional Cell Kill Hypothesis

Drug Development Value Chain

Patent Expiration Dates

Performance Status and Chemotherapy


Adoptive Cell Transfer Therapy

Genome-driven Therapy

Interferons and Interleukins

Checkpoint inhibitors

Oncogenes and oncogene addiction


Notch inhibitors

How vaccines function

Preventative vaccines

Treatment with vaccines

Early uses of vaccines

Gene Therapy for Cancer

Maintenance chemotherapy

Systemic therapy

Hormone Therapy

Coping with Chemo

Making Decision About Chemotherapy

Common Questions About Chemo


About the site

Privacy Policy


Quimioterapia Adyuvante

Quimioterapia Neoadyuvante

Explicación de los regímenes de quimioterapia de primera línea y de segunda línea

Resistencia a los medicamentos


Quimioterapia de Mantenimiento

Quimioterapia Combinada

Quimioterapia de Rescate

Tratamiento de Quimioterapia en Pacientes Ancianos con Cáncer

El Ciclo Reproductivo Celular Y Las Drogas Citotóxicas

Crítica a la Quimioterapia

Terapia Dirigida para el Tratamiento del Cáncer

Tratamiento Sistémico para el Cáncer

¿Quién Debería Recibir Quimioterapia?


Quimioterapia Oral

cancer symbol